Why BioPharma Lifecycle Management?
According to research by pharmamanufacturing.com, in excess of 60% of biopharma organizations are still managing many of their critical steps with paper and Microsoft Office.
The Biopharmaceutical industry has big ambitions to accelerate the move towards industry 4.0. In this whitepaper we explore some of the major bottlenecks in the development lifecycle, the current barriers to effective digital transformation and explore the role an effective BioPharmaceutical Lifecycle Management (BPLM) platform will play in accelerating time to market for vaccines and therapies.
- Time is of the essence in the biopharma space and it is being lost to poor data management
- Delays cost the company money and IP exclusivity, but most importantly they impact the patients
- Changes in data management can transform global health
Download our whitepaper to find out what an effective BPLM strategy can do for your organization!